Concepedia

Peng Duan

PD

Statistics

Publications

26

Citations

1K

H-Index

19

Active since

2008

Affiliations

Rutgers, The State University of New Jersey(Current)

Cedars-Sinai Medical Center

Center for Drug Evaluation and Research

United States Food and Drug Administration

Johnson University

Peng Duan is an author at Rutgers, The State University of New Jersey specializing in pharmacology, medicine, and oncology.

Publications per year

2008–2022

26

Publications

26

MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions

Boyang Jason Wu, Lijuan Yin, Changhong Shi et al. · Cancer Cell · 2017 · 130 citations · Full text

Medicine, Cancer Biology, Oncology +14

miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer

Murali Gururajan, Sajni Josson, Gina Chia‐Yi Chu et al. · Clinical Cancer Research · 2014 · 103 citations · Full text

Medicine, Molecular Biology, Oncology +17

Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis

Srinivas Nandana, Manisha Tripathi, Peng Duan et al. · Cancer Research · 2017 · 77 citations

Medicine, Cancer Biology, Oncology +17

Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)

Peng Duan, Ping Zhao, Lei Zhang · European Journal of Drug Metabolism and Pharmacokinetics · 2016 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway

Bo Kou, Wei Liu, Wei Zhao et al. · Oncology Reports · 2017 · 63 citations · Full text

Life Sciences, Oncology, Pharmacology +15

1–5 of 26